News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
208 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (18)
2 (269)
3 (285)
4 (247)
5 (261)
6 (107)
7 (40)
8 (30)
9 (292)
10 (264)
11 (234)
12 (208)
13 (114)
14 (2)
15 (9)
16 (225)
17 (227)
18 (243)
19 (266)
20 (124)
21 (3)
22 (2)
23 (119)
24 (14)
25 (1)
26 (39)
27 (24)
28 (1)
29 (2)
30 (88)
31 (41)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
LabTwin Recognized as a Finalist in the Fierce Innovation Awards – LifeSciences Edition 2019
LabTwin, the world’s first voice and AI-powered digital lab assistant, today announced that it has been selected as a finalist in Questex’s Fierce Innovation Awards – LifeSciences Edition 2019.
December 12, 2019
·
3 min read
Pharm Country
Gateway Health and Dasher Services, Inc. Welcome 600th Baby
Gateway Health and Dasher are pleased to announce a major milestone with the birth of their 600th baby.
December 12, 2019
·
2 min read
Biotech Bay
Colorcon/PWC/TruTag Technology Coalition Prove Out the Mass Digitalization of Pharma Pills
A coalition of technology partners announced today that they have demonstrated the mass digitalization of pharmaceutical tablets and their linkage to a Trillian based trust ledger.
December 12, 2019
·
3 min read
Global Osteoarthritis Therapeutics Market 2019-2023 | Evolving Opportunities With Bayer AG and Sanofi | Technavio
Technavio has announced its latest market research report titled global osteoarthritis therapeutics market 2019-2023
December 12, 2019
·
4 min read
Drug Development
Senhwa Biosciences Reports Positive Phase 1 Data of CX-5461 in Patients With Advanced Solid Tumors at 2019 SABCS
Evidence of human efficacy observed in patients with specific biomarkers and refractory to standard treatments including platinum and other chemotherapeutics
December 12, 2019
·
4 min read
Policy
CLSA Disappointed by House Passage of H.R. 3, Legislation That Will Short-Circuit Treatments for Patients and California Innovation
Congress passed legislation today, by a vote of 230-192, that will disrupt the nationwide life sciences ecosystem, leading to thousands of lost jobs, fewer cures for patients and less investment in new medicines
December 12, 2019
·
3 min read
Policy
SHAREHOLDER ALERT: WeissLaw LLP Investigates Synthorx, Inc.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Synthorx, Inc. in connection with the proposed acquisition of the Company by Sanofi SA.
December 12, 2019
·
1 min read
Drug Development
Significant Effect of Diamyd® in Type 1 Diabetes Shown in a New Comprehensive Analysis of Previous Phase III and Phase II Trials
When treatments with low number and high number dose regimens (two, three and four subcutaneous doses) were combined, a statistically significant treatment effect of approximately 40% was seen.
December 12, 2019
·
4 min read
Business
Akkad Holdings Asia and FKS Group Announce Global Partnership
The partnership will combine Akkad Holdings Asia’s expertise, proven entrepreneurial success and its exceptional network with the know-how, resources and the global reach of the FKS Group.
December 12, 2019
·
3 min read
BioMidwest
Centene Corporation Announces 2020 Guidance
Adjusted diluted earnings per share for 2020 are expected to be $4.64 to $4.84.
December 12, 2019
·
14 min read
Previous
4 of 21
Next